After Speaking with JBA this is what he responded to me;
"I appreciate you taking the time to understand what we are doing.
I have been the CEO since March 2016 and from the beginning the idea was to build credibility over time. The company had some unfortunate history in the past and we moved very slowly to insure that we understood the potential liabilities of controlling BLDV.
I started first by putting all of our family of companies under the BLDV umbrella, including our consulting firm established in 1939.
In addition we transitioned BLDV from Alternative Fuels and solar energy, to the cannabis space by putting our company Green Science and all of our network into Blue Diamond Consulting LLC.
The relationship with Cann10 started just over one year ago and today we are joint venture partners in Cann10 North America. Cann10 NA owns 13% of BLDV stock and BLDV controls 49% of Cann10 NA. This deal was closed on December 31st 2017, just 4 months ago.
The goal from the beginning was to find something of value to bring in BLDV and the merger that we are talking about would bring significant value and expand the governance of the company.
We do not partner with Israel in the dark, I had 2 Great-Grand Fathers at the first Zionist Congress, 2 grandfathers that fought in the British Foreign Legion in Palestine, my father worked as an Architect and construction manager in Israel for over 20 years. Currently my 91 year old mother lives there as well as my sister.
In 1982 my brother and I opened an import/export business bringing security and life safety products to Israel from the USA, this is still an operating entity run by my brother-in-law.
My brother lived in Israel for 25 years, I lived there for 5 years from 1983 to 1988.
Our partnership with Cann10 Israel is based on their confidence in our abilities and the integrity of our family and company.
This deal will bring BLDV into the BioTech world, real targeted therapies, Customized Formulations, Professional Education and Lucrative Consulting at the Biocannaceutical and Pharmaceutical Level.
Cann10 is active in 10 Countries but of course the USA and Canada are some of the most significant markets, the pipeline of innovation from Israel will run through Cann10 NA and BLDV.
Cann10 NA will be an aggressive player in the Cannabis Space in the USA and Canada, and over time will acquire holdings at all levels of the business. The AMS deal becomes stronger with Cann10 as part of the team.
As we streamline the structure of BLDV to accommodate the merger, I can assure you that nothing of value will leave BLDV without proper protection of the shareholders, and we have no intention of doing a reverse or other corporate action at this time that would dilute the current shareholders.
Please let me know if you have any more questions.
regards,
Josh
